NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
15 hedge funds and large institutions have $21.2M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
2% more capital invested
Capital invested by funds: $20.7M → $21.2M (+$515K)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.27M |
| 2 |
EEG
E.E. Geduld
|
+$431K |
| 3 |
OC
Oppenheimer & Co
New York
|
+$47.4K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$47.1K |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$24.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$190K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$150K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$125K |
| 4 |
Morgan Stanley
New York
|
-$74.7K |
| 5 |
Goldman Sachs
New York
|
-$22.7K |
NDRM Hedge Fund Activity: Q1 2015 in Review
15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q1 2015, worth a combined $21.2M — up 2.5% from $20.7M a quarter earlier.
Fund positioning in NDRM was balanced in Q1 2015: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $1.27M. The largest seller was Citadel Advisors, exiting entirely with an estimated $190K sold.
- 15 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $21.2M of NeuroDerm Ltd. Ordinary Shares stock for Q1 2015, up 2.5% quarter-over-quarter.
- 4 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q1 2015 and 4 closed out, a net change of 0 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q1 2015 was Acuta Capital Partners, an estimated $1.27M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q1 2015 was Citadel Advisors, an estimated $190K sold.
Based on aggregated 13F filings for Q1 2015.